|
⚲
|
| Keyboard |
| David Beier | |
|---|---|
| Firm | Bay City Capital GF Xinde Investment Management Co |
| Address | 750 Battery Street Suite 400 San Francisco, CA 94111 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Bay City Capital GF Xinde Investment Management Co | |||||
| Bay City Capital GF Xinde International Life Sciences USD Fund LP | 021-273681 | Director | of 200.0 M |
17.7 M | |
| Amgen Inc | 021-156628 | Executive Officer | of 2,500.0 M |
||
| ARYX Therapeutics Inc | 021-147064 | Director | 2.0 M of 5.0 M |
||
| ARYX Therapeutics Inc | 021-124990 | Director | 0.4 M of 35.4 M |
||